The practice, in which users inject the blood of already intoxicated individuals, has fueled one of the fastest-growing H.I.V. epidemics in the Pacific and grown widespread in South Africa.
Researchers sought to determine whether subcutaneous isatuximab would be an effective treatment for patients with RRMM.